Trilogy Capital Inc. Merck & Co., Inc. Transaction History

Trilogy Capital Inc.

$1.89 Billion
Q4 2024

A detailed history of Trilogy Capital Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Trilogy Capital Inc. holds 10,169 shares of MRK stock, worth $907,379. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,169

Previous 12,037 15.52%

Holding current value

$907,379

Previous $1.37 Million 25.99%

% of portfolio

0.05%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$96.31 - $114.76 $179,907 - $214,371	-1,868 Reduced 15.52%	10,169 $1.01 Million
Q3 2024 Oct 18, 2024	SELL	$111.15 - $128.97 $25,008 - $29,018	-225 Reduced 1.83%	12,037 $1.37 Million
Q2 2024 Jul 22, 2024	BUY	$123.8 - $132.96 $787,368 - $845,625	6,360 Added 107.76%	12,262 $1.52 Million
Q1 2024 Apr 17, 2024	BUY	$113.24 - $131.95 $352,402 - $410,628	3,112 Added 111.54%	5,902 $778,000
Q4 2023 Jan 11, 2024	BUY	$100.18 - $109.02 $43,778 - $47,641	437 Added 18.57%	2,790 $304,000
Q3 2023 Oct 16, 2023	SELL	$102.95 - $114.33 $101,508 - $112,729	-986 Reduced 29.53%	2,353 $242,000
Q2 2023 Jul 24, 2023	BUY	$108.61 - $118.38 $62,776 - $68,423	578 Added 20.93%	3,339 $385,000
Q1 2023 Apr 17, 2023	SELL	$102.94 - $114.86 $331,569 - $369,964	-3,221 Reduced 53.84%	2,761 $293,000
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $204,084 - $261,664	2,334 Added 63.98%	5,982 $663,000
Q3 2022 Oct 21, 2022	BUY	$84.53 - $94.96 $13,102 - $14,718	155 Added 4.44%	3,648 $314,000
Q2 2022 Jul 20, 2022	BUY	$83.49 - $94.64 $23,794 - $26,972	285 Added 8.88%	3,493 $318,000
Q1 2022 Apr 08, 2022	BUY	$73.51 - $82.4 $235,820 - $264,339	3,208 New	3,208 $263,000
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $689,329 - $786,219	-9,907 Closed	0 $0
Q4 2018 Jan 15, 2019	SELL	$65.24 - $75.71 $51,800 - $60,113	-794 Reduced 7.42%	9,907 $757,000
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $74,477 - $87,581	-1,291 Reduced 10.77%	10,701 $759,000
Q2 2018 Aug 20, 2018	SELL	$50.83 - $59.72 $11,385 - $13,377	-224 Reduced 1.83%	11,992 $728,000
Q1 2018 May 24, 2018	BUY	$50.96 - $59.23 $622,527 - $723,553	12,216 New	12,216 $665,000

Others Institutions Holding MRK

# of Institutions

3,972

Shares Held

1.86B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $226B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.

Account

Trilogy Capital Inc. Merck & Co., Inc. Transaction History